PTC Therapeutics ( (PTCT) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
PTC Therapeutics’ stock has experienced a downward movement primarily due to negative corporate insider sentiment, as there has been an increase in insider selling. Despite the company’s strong R&D capabilities and a successful Sephience launch, analysts have mixed ratings on the stock. Current price targets are varied, reflecting differing opinions on the stock’s future potential, especially in light of recent earnings that showed improved financials but still warrant cautious optimism.
More about PTC Therapeutics
YTD Price Performance: 72.62%
Average Trading Volume: 1,541,744
Technical Sentiment Signal: Buy
Current Market Cap: $6.36B
For further insights into PTCT stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.